Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer...
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Purpose
Isolated tumor cells (ITC) in the bone marrow of breast cancer patients increase the risk of recurrence and decrease survival, both at primary diagnosis and during follow-up. We tested the efficacy of trastuzumab in clearing HER2/neu-positive ITC from the marrow of patients completing primary treatment.
Methods
Ten recurrence-free...
Alternative Titles
Full title
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_916148288
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_916148288
Other Identifiers
ISSN
0932-0067
E-ISSN
1432-0711
DOI
10.1007/s00404-011-1954-2
